Mechanistically, tranilast facilitated ECM remodeling by reducing TGFβ1 expression, thereby inhibiting Smad2/3 phosphorylation, and suppressing TGFβ-mediated expression of COL1A1, connective tissue growth factor (CTGF), and hyaluronan synthase 2 (HAS2) in MCF10CA1a tumor xenografts. This evidence concerns the gene HAS2 and neoplasm.